Urgent Ozempic warning every Aussie needs to hear as concerning trend emerges: 'Follow the instructions'
The NSW Poisons Information Centre received 332 distressed calls in 2024 from patients using semaglutide - a type 2 diabetes injection that trades under brand names such as Ozempic and Wegovy.
Calls seeking advice on poisonings from semaglutide spiked by 1,176 per cent in four years, the Daily Telegraph reported
Hospital management was required in 21 per cent of cases. In 2020, just 26 residents called the centre for help.
NSW Poisons Information Centre senior specialist Genevieve Adamo said semaglutide was a GLP-1 agonist used to treat type 2 diabetes, but more recently had gained popularity among the public for off-label use for weight loss.
'To prevent accidental medication errors from GLP-1 agonists, NSW PIC advises the community to always write down or mark off the dose on a chart and always follow the instructions on the label,' she said.
'Ensure your doctor, diabetes educator, nurse or pharmacist has given you clear instructions on how to use your medicine, particularly on how to load a dose and inject correctly.'
Common symptoms of semaglutide overdose include persistent nausea, vomiting, and diarrhoea, as well as intense headaches and hypoglycaemia (blood sugar).
More serious side effects that require immediate medical attention include acute pancreatitis and gallstones.
Last year, the PBS recorded more than 2.5 million prescriptions across Australia, a massive jump from 45,705 scripts in 2020 when the drug was first listed on the PBS.
The Therapeutic Goods Administration (TGA) has not approved Ozempic for weight loss, while Mounjaro and Wegovy can be prescribed for fat-loss purposes in 'very limited' cases.
The TGA announced this month that Novo Nordisk, the pharmaceutical company that supplied Ozempic, had doubled the dose contained in the pre-filled pens from 1.5mL to 3mL.
The new 3 mL pen landed on chemist shelves this month and injects a slightly larger volume per dose.
The TGA urged doctors to warn Ozempic users to 'be careful' and check the dose before administering it.
Earlier this month, official data revealed more than 100 deaths in the United Kingdom had now been linked to blockbuster weight loss jabs.
Two of the victims were people in their 20s, according to a MailOnline analysis of logs kept by the medicines safety watchdog.
The findings come as the Medicines and Healthcare Products Regulatory Agency confirmed at least ten people in the UK who used the injections have died from pancreatitis, a life-threatening inflammation of the pancreas.
The country's Royal Osteoporosis Society has also linked weight loss drugs to osteoporosis and increased risk of bone fractures.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Exclusive: CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists
Aug 20 (Reuters) - CVS Health (CVS.N), opens new tab, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' (GILD.O), opens new tab new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness. CVS based the decision on clinical, financial, and regulatory factors, spokesperson David Whitrap said in an email. It also will not cover Yeztugo under its Affordable Care Act formularies, since its ACA preventive program follows recommendations and mandates from the U.S. Department of Health and Human Services (HHS), Whitrap said. Current HIV prevention recommendations from the U.S. Preventive Services Task Force (USPSTF), which is supported by HHS, include only three older drugs. A source familiar with the situation suggested that Gilead is still negotiating with CVS over Yeztugo, a twice-yearly injection with a U.S. list price of more than $28,000 a year. The decision by CVS is "a grave disappointment and frankly a missed opportunity," said Mitchell Warren, executive director of the AIDS nonprofit AVAC. "It does reflect a price that is too high and a U.S. pharmaceutical pricing structure that is frankly not sustainable." He and other AIDS activists have said Yeztugo could be a transformative tool in ending the 44-year-old epidemic that infects 1.3 million people a year and is estimated by the World Health Organization to have killed more than 42 million. Pharmacy benefit managers, or PBMs, act as middlemen between drug companies and consumers. They negotiate volume discounts with drug manufacturers on behalf of employers and health plans based on coverage terms. The three largest - CVS Caremark, UnitedHealth Group's (UNH.N), opens new tab OptumRX and Cigna's (CI.N), opens new tab Express Scripts - control about 70%, opens new tab of specialty drug prescriptions in the U.S. Optum said Yeztugo will be reviewed for coverage in the coming weeks, while Express Scripts did not respond to requests for comment. Gilead, which declined to comment, said earlier this month it is on track to secure 75% U.S. insurer coverage of Yeztugo by year-end and 90% coverage by June 2026. Its CEO, Daniel O'Day, has said that half of every dollar spent on medicines in the U.S. goes to PBMs and other entities that do not make drugs. U.S. government healthcare programs, including the Veterans Administration and the Medicare program for people over age 65, have already added Yeztugo to coverage lists. Gilead said earlier this month that several state-run Medicaid plans, including California and New York, were covering the drug. Gilead, its investors, and AIDS activists have high hopes for Yeztugo. Approved in June for people at high risk of HIV, the drug was shown to be nearly 100% effective at preventing infection in large trials, fueling fresh optimism about limiting the spread of HIV. Some analysts have warned that a recent Supreme Court ruling affirming broad HHS authority, opens new tab over the USPSTF could affect coverage prospects while Robert F. Kennedy Jr is in charge of the agency. Medical groups have expressed alarm about reports that Kennedy could replace members of the task force. The 16-member task force reviews evidence and public input, then recommends preventive services that catch disease early or prevent worsening, which insurers must cover without patient cost-sharing. For HIV prevention, it endorses daily PrEP pills Truvada, which is available as a generic, and Gilead's Descovy, as well as ViiV Healthcare's bimonthly shot Apretude. Gilead's O'Day has stressed that the lifetime cost of treating an HIV patient can exceed $1 million, making a preventive treatment cost effective.
The Guardian
2 hours ago
- The Guardian
Excessive sleepiness: are you always tired? Doctors may finally have a cure
Name: Excessive daytime sleepiness. Age: First described in 1976. Appearance: You, asleep in the clothes you went to work in. Surely it's natural to feel a bit sleepy during the day? Yes, but that isn't what this is. The important part of the equation is the 'excessive'. If you're always falling asleep outside bedtime hours, that's a problem. Oh, you really do mean excessive. Yes. And it's a condition recognised by the NHS, with the medical name hypersomnia. Narcolepsy? No, narcolepsy is a neurological condition that causes people to suddenly fall into deep sleeps. Hypersomnia is where you're so tired that you keep drifting off. Now I'm worried that I may have it. Well, answer me this: do you eat a lot of cheese, gherkins and smoked meat? Now you mention it, I do maintain a primarily charcuterie-based diet. Well, that might be your problem. Researchers from Brigham and Women's hospital in Boston have claimed that hypersomnia may have a lot to do with our metabolism. Worrying. Not really. The researchers say that the metabolite tyramine is a factor. Tyramine is found in overripe food, aged cheese, smoked meat and some alcoholic drinks. Wow, medieval kings must have been absolutely knackered all the time. It's suggested that if people feel constantly sleepy, they should ditch these foods and adopt a diet of seeds, nuts and vegetable oils. And the result is that you'll have more hours in the day to eat all this boring food? Exactly. Don't dismiss hypersomnia, though. There is a test you can take, the Epworth Sleepiness Scale, to discover if your napping is a problem or not. I just scored really highly on it. The NHS recommends that you should see your GP if you fall asleep during the day too often. Why bother? I'll just lay off the gouda and everything will be dandy. Out of interest, do you snore a lot? How rude! Maybe. If you do, you may have sleep apnoea, and your daytime sleepiness could be down to your inability to reach a point of deep, restorative sleep at night. Also, are you depressed? Isn't everyone? That's another potential cause of hypersomnia. What if I'm depressed because someone from Boston just told me that I can't eat so much antipasti? Oh dear, that means you're trapped in a rare but dangerous hypersomnia loop. Maybe just give in to it. Nothing wrong with an impromptu nap, is there? I'm a commercial airline pilot. Forget everything I just said. Eat these seeds immediately. Do say: 'Smoked meat causes excessive daytime sleepiness.' Don't say: 'And also cures it, if you use a Peperami to prop your eyelids open.'
Telegraph
3 hours ago
- Telegraph
Mounjaro is almost tripling in price – here's what it means for you
Its amazing results have been hailed by Jeremy Clarkson, Whoopi Goldberg and The Telegraph 's own Allison Pearson, but from next month, the popular weight-loss drug Mounjaro could become inaccessible to many people across the UK. The wholesale price of the medication is set to shoot up by 170 per cent from September 1, with the highest dose (15mg) increasing from £122 per month to £330. Mounjaro (also known as tirzepatide) is an injectable drug made from a synthetic 'analogue' of the two molecules GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide). These hormones, which are also produced naturally in the brain, regulate appetite and insulin production. 'The main effect of the hormones in Mounjaro is to tell you that you are 'full',' says Prof Ketan Dhatariya, a consultant in diabetes, endocrinology and general medicine at Norfolk and Norwich University Hospital. 'Imagine you've been invited to a friend's house for dinner, and the food isn't ready yet, so you fill up on Twiglets and Pringles. But when the meal is served, you are no longer hungry and you can't eat a thing.' Patients can get the medication through an NHS prescription, or more commonly from a private provider such as Boots, MedExpress or Pharmacy2U. Why is the price increasing? American pharmaceutical companies have faced pressure from Donald Trump to make drugs more affordable by offsetting higher prices to other countries, including the UK. Until now, UK providers have paid significantly lower wholesale prices than other European countries, meaning patients have been able to pay a reduced monthly fee. What will the price change be and when will it come into effect? Pharmacies in the UK currently pay between £92 and £122 for the drug, depending on the price. From September 1, a 2.5mg dose will cost £133, and the higher doses, 12.5mg and 15mg, will cost £330. Some companies, such as Pharmacy2U, have confirmed that their retail prices will freeze for the foreseeable future. Boots has confirmed that its prices will change but that it will do its best to keep them fair and accessible. Why do costs vary? Costs will vary depending on the provider and the dose. There are six strengths of Mounjaro: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. The higher the dose, the more expensive the monthly cost. How do the price rises in the UK compare with Europe and the United States? In the UK, the highest dose of Mounjaro currently costs £122. In the US, the same dose costs roughly $1,000 (£743) without insurance. Inish Pharmacy, Ireland's leading online pharmacy, charges €289 (£250) for 2.5mg of Mounjaro and the higher doses of 7.5mg and 10mg cost €465 (£402). In Spain, patients can expect to pay an average of €271 (£235) per month and in France, a 5mg dose costs around €250 (£217). Eli Lilly, the US manufacturer of Mounjaro, originally set lower prices in the UK to avoid long supply delays, ease waiting-list pressures and compete with other GLP-1 medications. I'm on Mounjaro. What should I do next? It will depend on how you get your medication. If you get your prescription through the NHS, you are likely to be unaffected. Eli Lilly has agreed a separate supply arrangement with the NHS, which ensures that prices will remain stable. If you receive your medication through a private provider, you could speak with it directly to see whether it is offering discounts. Alternatively, you could switch to a provider with lower costs, such as Pharmacy2U. If you're thinking about switching to a cheaper medication entirely, Wegovy and Rybelsus are also available in the UK, as well as Ozempic – a type 2 diabetes medication that is prescribed off-label for weight loss. How can I get Mounjaro for free? The NHS offers Mounjaro for those who need it as part of their primary care. In order to qualify, you would need to have a body mass index (BMI) of 40 (or 37.5 for ethnic minorities) or above, and at least four weight-linked health conditions such as: Type 2 diabetes High blood pressure Heart disease Abnormal cholesterol or blood fats Obstructive sleep apnoea (a sleep-related breathing problem) In June 2026, it will expand to include people with a BMI of 35 to 39.9 who have four of the conditions listed above. In April 2027, it will also be offered to people with a BMI of 40 and above who have just three out of the five conditions. How can I find a reputable provider? The recent update has caused concern among some GPs that patients unable to afford the new prices may turn to the black market for the drug out of desperation. Patients should ensure that any potential Mounjaro provider is registered with the General Pharmaceutical Council or the Care Quality Commission. They can also check customer satisfaction through sites such as Trustpilot. Pharmacies attached to high-street companies such as Boots, Asda, Lloyds Pharmacy and Superdrug can typically be trusted. What are some of the alternatives to Mounjaro? Ozempic In the UK, Ozempic is licensed only as a type 2 diabetes treatment. It is possible to find a private doctor who is willing to prescribe Ozempic for weight loss outside of licensed conditions, but NHS doctors cannot. Because of this, it is recommended that patients use Wegovy instead, as it uses the same active ingredient (semaglutide). Private providers may charge between £150 and £180 for the lowest dose (0.25mg) to £165-£180 for the highest dose (1mg). Wegovy Wegovy is a version of Ozempic that can be prescribed for weight loss. The dosing of Wegovy is more clinically suitable for weight loss and ranges between £118.98 for the lowest dose (0.25mg) and £188.98 for the highest (2.4mg). It is seen as a safer, more effective option than Ozempic. Rybelsus Rybelsus is a tablet GLP-1 medication used to treat type 2 diabetes. Like Ozempic, it is not licensed for weight loss but it also contains semaglutide and can sometimes be prescribed 'off-label'. Rybelsus can be prescribed for free by the NHS, or off-label prescriptions can be purchased from private doctors and pharmacies for between £150 and £400, depending on the number of tablets. Can I order multiple pens now so I don't have to buy them after the price rise? Reorders depend on the provider. Boots is allowing patients to purchase up to three pens in advance before September 1. Some pharmacies such as Lloyds Pharmacy are selling medication only to existing customers, and allowing only one reorder per patient. Can I stay on Mounjaro for ever? Yes, you can use Mounjaro in the long term, says Dr Kaywaan Khan, a GP and weight loss and wellbeing specialist at Hannah London. Some people 'will take the medication for ever because they not only have obesity as a chronic disease, but they [have conditions such as] heart disease or diabetes, so taking this medication is part of their core health treatment and preventative health care', Dr Khan adds. Can I switch from Mounjaro to Wegovy? You should not take Mounjaro and Wegovy at the same time. If you decide to switch, you should wait at least a week before taking the new medication. You should also increase your dose gradually.
